tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
US Market
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
RESEARCH TOOLSreports

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Cash flow

26 Followers

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow

SFOSF's free cash flow for Q4 2025 was ¥551.55M. For the 2025 fiscal year, SFOSF's free cash flow was decreased by ¥697.99M and operating cash flow was ¥1.83B. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
¥ 5.21B¥ 4.48B¥ 3.41B¥ 4.22B¥ 3.95B
Investing Cash Flow
¥ -2.15B¥ -3.61B¥ -3.82B¥ -4.06B¥ -3.86B
Financing Cash Flow
¥ -3.24B¥ -1.00B¥ -1.34B¥ 4.43B¥ -831.28M
End Cash Position
¥ 9.04B¥ 9.39B¥ 9.50B¥ 11.17B¥ 6.45B
Free Cash Flow
¥ 764.78M¥ 66.79M¥ -1.92B¥ -1.67B¥ -1.02B
Currency in CNY

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow